-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Dolphin Congratulates Shore Fire Media and Its Clients on 20 GRAMMY(R) Nominations, Including 10 Best Album Nods Across Diverse Genres
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
5E Advanced Materials Highlights Commercial Momentum in First Month as an Operating Borates Producer
-
Trout CPA Expands Partner Leadership with Michael Carr and Dan Lerew
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Jumia Reports Third Quarter 2026 Results
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
What to Do When Two Households Become One
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
Narcolepsy, cancer tipped as Medicine Prize opens Nobel week
Narcolepsy, cancer or mRNA vaccine research could win the Nobel Medicine Prize on Monday when a week of announcements kick off, but experts see no clear frontrunner for the Peace Prize.
The awards, first handed out in 1901, were created by Swedish inventor and philanthropist Alfred Nobel in his 1895 will to celebrate those who have "conferred the greatest benefit on mankind."
The Medicine Prize is first out, and will be announced in Stockholm on Monday around 11:30 am (0930 GMT), followed by the awards for physics on Tuesday, chemistry on Wednesday and literature on Thursday.
The Peace Prize, the most highly-anticipated Nobel and the only one announced in Oslo, will follow on Friday, before the Economics Prize rounds things off on October 9.
The Medicine Prize has over the years crowned groundbreaking discoveries like the X-ray, penicillin, insulin and DNA -- as well as now-disgraced awards for the lobotomy and the insecticide DDT.
Several Nobel watchers have suggested this year's prize could go to research into narcolepsy and the discovery of orexin, a neuropeptide that helps regulate sleep.
It could also go to Hungarian-born Katalin Kariko and Drew Weissman of the United States for research that led directly to the first mRNA vaccines to fight Covid-19, made by Pfizer and Moderna.
Their discovery has already won a slew of major medicine prizes, but the Nobel committee nowadays often waits decades to bestow its laurels to ensure the research stands the test of time.
"Maybe the Academy thinks it needs to look into it more, but someday they should win," predicted Annika Ostman, science reporter at Swedish public radio SR.
- Gene engineering and IceCube telescope -
But Ostman said her guess for this year was on Kevan Shokat, an American biologist who figured out how to block the KRAS cancer gene behind a third of cancers, including challenging-to-treat lung, colon, and pancreatic tumours.
T-cell therapy for cancer treatment and work on the human microbiome could also be contenders, said David Pendlebury, head of the Clarivate analytics group which identifies Nobel-worthy research.
"There are more people deserving of a Nobel Prize than there are Nobels to go around," he told AFP.
Lars Brostrom, Ostman's colleague at SR, singled out two American biologists, Stanislas Leibler and Michael Elowitz, for their work on synthetic gene circuits which established the field of synthetic biology.
It enables scientists to redesign organisms by engineering them to have new abilities.
But Brostrom noted the field could be seen as controversial, raising "ethical questions about where to draw the line in creating life".
For the Physics Prize, twisted graphene or the IceCube Neutrino Observatory in Antarctica were seen as possible winners, as well as the development of high-density data storage in the field of spintronics.
- Peace Prize to Iranian women? -
For Wednesday's Chemistry Prize, Pendlebury suggested next-generation DNA sequencing could get the nod, or research into how to target and deliver drugs to genes.
Brostrom said he would love to see it go to US-based chemist Omar Yaghi for his work into porous materials known as MOFs, which can absorb poisonous gases or harvest water from desert air, and is an "important field for the future" with enormous potential for the environment.
Criticism over a lack of gender and geographical diversity has plagued the Nobels over the years.
US-based men have dominated the science fields, while women account for just six percent of overall laureates -- something the various award committees insist they are addressing.
Among the names making the rounds for Thursday's Literature Prize are Russian author and outspoken Putin critic Lyudmila Ulitskaya, Chinese avant-garde writer Can Xue, British author Salman Rushdie, Caribbean-American writer Jamaica Kincaid and Norwegian playwright Jon Fosse.
But for the Peace Prize, experts have been scratching their heads over possible winners, as conflicts rage around the globe.
Some have pointed to the Iranian women protesting since the death in custody a year ago of Mahsa Amini, arrested for violating Iran's strict dress code imposed on women.
Others suggest organisations documenting war crimes in Ukraine, or the International Criminal Court, which could one day be called upon to judge them.
"I think that climate change is a really good focus for the Peace Prize this year," Dan Smith, the head of the Stockholm International Peace Research Institute, told AFP after a year of extreme weather around the world.
For the Economics Prize, research on income and wealth inequality could be honoured.
M.White--AT